VEXMX vs. AGIO
Compare and contrast key facts about Vanguard Extended Market Index Fund (VEXMX) and Agios Pharmaceuticals, Inc. (AGIO).
VEXMX is managed by Vanguard. It was launched on Dec 21, 1987.
Performance
VEXMX vs. AGIO - Performance Comparison
Loading graphics...
VEXMX vs. AGIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VEXMX Vanguard Extended Market Index Fund | -1.29% | 10.93% | 15.05% | 26.79% | -26.56% | 12.31% | 32.43% | 27.87% | -9.48% | 17.94% |
AGIO Agios Pharmaceuticals, Inc. | 25.61% | -17.16% | 47.55% | -20.69% | -14.57% | -24.14% | -9.26% | 3.56% | -19.35% | 37.00% |
Returns By Period
In the year-to-date period, VEXMX achieves a -1.29% return, which is significantly lower than AGIO's 25.61% return. Over the past 10 years, VEXMX has outperformed AGIO with an annualized return of 10.75%, while AGIO has yielded a comparatively lower -2.00% annualized return.
VEXMX
- 1D
- 3.44%
- 1M
- -5.36%
- YTD
- -1.29%
- 6M
- -1.43%
- 1Y
- 19.99%
- 3Y*
- 14.71%
- 5Y*
- 3.74%
- 10Y*
- 10.75%
AGIO
- 1D
- 1.06%
- 1M
- 17.09%
- YTD
- 25.61%
- 6M
- -14.67%
- 1Y
- 24.78%
- 3Y*
- 14.18%
- 5Y*
- -8.26%
- 10Y*
- -2.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VEXMX vs. AGIO — Risk / Return Rank
VEXMX
AGIO
VEXMX vs. AGIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard Extended Market Index Fund (VEXMX) and Agios Pharmaceuticals, Inc. (AGIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VEXMX | AGIO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.90 | 0.35 | +0.55 |
Sortino ratioReturn per unit of downside risk | 1.40 | 0.93 | +0.46 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.20 | -0.01 |
Calmar ratioReturn relative to maximum drawdown | 1.38 | 0.33 | +1.05 |
Martin ratioReturn relative to average drawdown | 5.65 | 0.70 | +4.95 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| VEXMX | AGIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.90 | 0.35 | +0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | -0.14 | +0.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.48 | -0.03 | +0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.01 | +0.51 |
Correlation
The correlation between VEXMX and AGIO is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
VEXMX vs. AGIO - Dividend Comparison
VEXMX's dividend yield for the trailing twelve months is around 1.03%, while AGIO has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VEXMX Vanguard Extended Market Index Fund | 1.03% | 0.74% | 0.74% | 1.14% | 1.00% | 0.99% | 1.19% | 1.18% | 1.52% | 1.12% | 1.31% | 1.20% |
AGIO Agios Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
VEXMX vs. AGIO - Drawdown Comparison
The maximum VEXMX drawdown since its inception was -58.17%, smaller than the maximum AGIO drawdown of -87.36%. Use the drawdown chart below to compare losses from any high point for VEXMX and AGIO.
Loading graphics...
Drawdown Indicators
| VEXMX | AGIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.17% | -87.36% | +29.19% |
Max Drawdown (1Y)Largest decline over 1 year | -14.63% | -50.89% | +36.26% |
Max Drawdown (5Y)Largest decline over 5 years | -36.38% | -72.16% | +35.78% |
Max Drawdown (10Y)Largest decline over 10 years | -41.63% | -82.86% | +41.23% |
Current DrawdownCurrent decline from peak | -7.19% | -74.68% | +67.49% |
Average DrawdownAverage peak-to-trough decline | -11.19% | -58.57% | +47.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.57% | 23.81% | -20.24% |
Volatility
VEXMX vs. AGIO - Volatility Comparison
The current volatility for Vanguard Extended Market Index Fund (VEXMX) is 7.02%, while Agios Pharmaceuticals, Inc. (AGIO) has a volatility of 15.62%. This indicates that VEXMX experiences smaller price fluctuations and is considered to be less risky than AGIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| VEXMX | AGIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.02% | 15.62% | -8.60% |
Volatility (6M)Calculated over the trailing 6-month period | 13.51% | 79.68% | -66.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.99% | 71.01% | -48.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.38% | 57.37% | -34.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.35% | 57.30% | -34.95% |